| Jul 13 | Jul 12 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | ||
| Gross Profit | $ 0.00 | - |
| Operating Income | $ -39.09K | - |
| EBITDA | $ -39.02K | - |
| Net Income | $ -39.09K | - |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ ― | $ ― |
| Total Assets | $ 388.00 | $ 7.78K |
| Total Debt | $ 0.00 | $ 0.00 |
| Net Debt | $ -105.00 | $ -7.78K |
| Total Liabilities | $ 21.93K | $ 4.10K |
| Stockholders' Equity | $ ― | $ ― |
| Cash Flow | ||
| Free Cash Flow | $ -39.37K | - |
| Operating Cash Flow | $ -39.02K | - |
| Investing Cash Flow | ||
| Financing Cash Flow |
Life Stem Genetics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.